Patent Application
Utility
App. No. 14/218,508
· Confirmation No. 3239
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2018-08-08 | ABN |
Abandonment | 2 | View | |
| 2018-07-24 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2018-07-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2018-04-17 | CTAV |
Advisory Action (PTOL-303) | 3 | View | |
| 2018-04-17 | ANE.I |
Amendment After Final or under 37CFR 1.312, initialed by the examiner. | 1 | View | |
| 2018-03-26 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2018-03-26 | A.NE |
Response After Final Action | 1 | View | |
| 2018-03-26 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2018-03-26 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2018-03-26 | CLM |
Claims | 7 | View | |
| 2018-01-24 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2018-01-24 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2018-01-24 | CTFR |
Final Rejection | 14 | View | |
| 2017-09-26 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2017-09-26 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2017-09-26 | CLM |
Claims | 7 | View | |
| 2017-09-26 | REM |
Applicant Arguments/Remarks Made in an Amendment | 4 | View | |
| 2017-09-26 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2017-09-26 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2017-05-26 | CTNF |
Non-Final Rejection | 23 | View | |
| 2017-05-26 | SRNT |
Examiner's search strategy and results | 4 | View | |
| 2017-05-26 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2017-05-26 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2017-05-02 | RCEX |
Request for Continued Examination (RCE) | 2 | View | |
| 2017-05-02 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | 1 | View | |
| 2017-05-02 | CLM |
Claims | 7 | View | |
| 2017-05-02 | REM |
Applicant Arguments/Remarks Made in an Amendment | 4 | View | |
| 2017-05-02 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2017-05-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2017-05-02 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2016-11-02 | CTFR |
Final Rejection | 20 | View | |
| 2016-11-02 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2016-11-02 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2016-07-15 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2016-07-15 | CLM |
Claims | 7 | View | |
| 2016-07-15 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2016-07-15 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2016-07-15 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2016-07-15 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2016-01-15 | CTNF |
Non-Final Rejection | 20 | View | |
| 2016-01-15 | 892 |
List of references cited by examiner | 1 | View | |
| 2016-01-15 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2016-01-15 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2016-01-15 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2015-12-07 | ELC. |
Response to Election / Restriction Filed | 1 | View | |
| 2015-12-07 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2015-12-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2015-12-03 | INTV.SUM.APP |
Applicant Initiated Interview Summary (PTOL-413) | 3 | View | |
| 2015-10-05 | CTRS |
Requirement for Restriction/Election | 6 | View | |
| 2015-01-08 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2014-09-26 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2014-09-26 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2014-09-26 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2014-09-19 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 2 | View | |
| 2014-09-19 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2014-09-19 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2014-09-19 | SPEC |
Specification | 102 | View | |
| 2014-09-19 | CLM |
Claims | 7 | View | |
| 2014-09-19 | ABST |
Abstract | 1 | View | |
| 2014-09-19 | REM |
Applicant Arguments/Remarks Made in an Amendment | 111 | View | |
| 2014-09-19 | DRW.NONBW |
Drawings-other than black and white line drawings | 27 | View | |
| 2014-09-19 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2014-04-11 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2014-04-11 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2014-04-11 | NT.CR.APP.PA |
Notice to File Corrected Application Papers | 2 | View | |
| 2014-03-18 | SPEC |
Specification | 102 | View | |
| 2014-03-18 | CLM |
Claims | 7 | View | |
| 2014-03-18 | ABST |
Abstract | 1 | View | |
| 2014-03-18 | DRW |
Drawings-only black and white line drawings | 26 | View | |
| 2014-03-18 | ADS |
Application Data Sheet | 7 | View | |
| 2014-03-18 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2014-03-18 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 0001-01-03 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View |
Inventors
Bonnie Hepburn
Escondido, CA
Barry Goldlust
San Diego, CA
Attorneys & Agents of Record
Classification
USPC
424/400
A61K31/4439
A61K9/0095
A61K45/06
A61K47/02
Prosecution
- Examiner
- POLANSKY, GREGG
- Art Unit
- 1621
- Customer No.
- 120260
- Docket No.
- 20215.0035.CNUS00
- Confirmation No.
- 3239
Publication
- Pub. No.
- US20150011588A1
- Pub. Date
- 2015-01-08
Parent
is a Continuation of
→
App. 10/938,766
Filed 2004-09-10
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation in-part of
→
App. 10/783,871
Filed 2004-02-20
· Abandoned -- Failure to Respond to an Office Action
Parent
Claims priority from a provisional application
→
App. 60/448,627
Filed 2003-02-20
· Provisional Application Expired
Child
is a Continuation of
→
App. 16/044,342
Filed 2018-07-24
· Abandoned -- Incomplete Application (Pre-examination)
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, LTD.,
SALIX PHARMACEUTICALS, INC.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS IRELAND LIMITED
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
from
GLYCYX PHARMACEUTICALS, LTD.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.
SECURITY AGREEMENT
Recorded 2015-04-02
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 14/218,508
- Filed
- 2014-03-18
- Pub. No.
- US20150011588A1
- Examiner
- POLANSKY, GREGG
- Art Unit
- 1621
External Links